IRIS Accounts Production v24.3.2.46 14944533 Board of Directors 19.6.23 30.6.24 30.6.24 false true false false false true false Ordinary share 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh149445332023-06-18149445332024-06-30149445332023-06-192024-06-30149445332023-06-1814944533ns15:EnglandWales2023-06-192024-06-3014944533ns14:PoundSterling2023-06-192024-06-3014944533ns10:Director12023-06-192024-06-3014944533ns10:PrivateLimitedCompanyLtd2023-06-192024-06-3014944533ns10:SmallEntities2023-06-192024-06-3014944533ns10:AuditExempt-NoAccountantsReport2023-06-192024-06-3014944533ns10:SmallCompaniesRegimeForDirectorsReport2023-06-192024-06-3014944533ns10:SmallCompaniesRegimeForAccounts2023-06-192024-06-3014944533ns10:FullAccounts2023-06-192024-06-301494453312023-06-192024-06-3014944533ns10:OrdinaryShareClass12023-06-192024-06-3014944533ns10:Director22023-06-192024-06-3014944533ns10:Director32023-06-192024-06-3014944533ns10:Director42023-06-192024-06-3014944533ns10:RegisteredOffice2023-06-192024-06-3014944533ns5:CurrentFinancialInstruments2024-06-3014944533ns5:ShareCapital2024-06-3014944533ns5:RetainedEarningsAccumulatedLosses2024-06-3014944533ns5:ComputerSoftware2023-06-192024-06-3014944533ns5:ComputerSoftware2024-06-3014944533ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3014944533ns10:OrdinaryShareClass12024-06-30
REGISTERED NUMBER: 14944533 (England and Wales)










DMC Dermatology Limited

Unaudited Financial Statements

for the Period 19 June 2023 to 30 June 2024






DMC Dermatology Limited (Registered number: 14944533)






Contents of the Financial Statements
for the Period 19 June 2023 to 30 June 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


DMC Dermatology Limited

Company Information
for the Period 19 June 2023 to 30 June 2024







DIRECTORS: Dr S Clark
Mrs L Shipley
Mr S J Elsworth
Dr M J Judah





REGISTERED OFFICE: 31 Sackville Street
Manchester
England
M1 3LZ





REGISTERED NUMBER: 14944533 (England and Wales)






DMC Dermatology Limited (Registered number: 14944533)

Balance Sheet
30 June 2024

Notes £   
FIXED ASSETS
Intangible assets 5 6,200

CURRENT ASSETS
Debtors 6 256,432
Cash at bank 284,357
540,789
CREDITORS
Amounts falling due within one year 7 (165,832 )
NET CURRENT ASSETS 374,957
TOTAL ASSETS LESS CURRENT
LIABILITIES

381,157

CAPITAL AND RESERVES
Called up share capital 8 100
Retained earnings 381,057
SHAREHOLDERS' FUNDS 381,157

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DMC Dermatology Limited (Registered number: 14944533)

Balance Sheet - continued
30 June 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 March 2025 and were signed on its behalf by:





Mr S J Elsworth - Director


DMC Dermatology Limited (Registered number: 14944533)

Notes to the Financial Statements
for the Period 19 June 2023 to 30 June 2024

1. GENERAL INFORMATION

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
31 Sackville Street
Manchester
M1 3LZ
England

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

3. ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND KEY ACCOUNTING ESTIMATES
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

BASIS OF PREPARATION
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

REVENUE RECOGNITION
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company's activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

TAX
The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

AMORTISATION
Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class Amortisation method and rate
Computer software 15% WDV method

CASH AND CASH EQUIVALENTS
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

DMC Dermatology Limited (Registered number: 14944533)

Notes to the Financial Statements - continued
for the Period 19 June 2023 to 30 June 2024

TRADE DEBTORS
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

TRADE CREDITORS
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

BORROWINGS
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

SHARE CAPITAL
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 4 .

DMC Dermatology Limited (Registered number: 14944533)

Notes to the Financial Statements - continued
for the Period 19 June 2023 to 30 June 2024

5. INTANGIBLE FIXED ASSETS
Computer
software
£   
COST
Additions 6,889
At 30 June 2024 6,889
AMORTISATION
Amortisation for period 689
At 30 June 2024 689
NET BOOK VALUE
At 30 June 2024 6,200

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 252,948
Other debtors 3,484
256,432

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 164,414
Other creditors 1,418
165,832

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
100 Ordinary share 1 100